Risk Classification of Patients With Advanced Urothelial Carcinoma Treated With Enfortumab Vedotin.
Ishikawa G, Matsushita Y, Kitagawa Y, Uchiyama A, Oishi Y, Tanaka H, Watanabe S, Suzuki E, Watanabe S, Watanabe K, Watanabe H, Tamura K, Motoyama D, Matsumoto R, Ito T, Nagata M, Unno T, Furuse H, Mizuno T, Otsuka A.
Ishikawa G, et al. Among authors: kitagawa y.
Cancer Diagn Progn. 2024 Nov 3;4(6):783-788. doi: 10.21873/cdp.10396. eCollection 2024 Nov-Dec.
Cancer Diagn Progn. 2024.
PMID: 39502620
Free PMC article.